BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30630205)

  • 1. A Unique Factor XIII Mutation in Southeastern Iran with an Unexpectedly High Prevalence: Khash Factor XIII.
    Dorgalaleh A; Tabibian S; Shams M; Majid G; Naderi M; Casini A; Tavasoli B; Gheidishiran M; Daneshi M; Safa M
    Semin Thromb Hemost; 2019 Feb; 45(1):43-49. PubMed ID: 30630205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations and management of life-threatening bleeding in the largest group of patients with severe factor XIII deficiency.
    Naderi M; Dorgalaleh A; Alizadeh S; Tabibian S; Hosseini S; Shamsizadeh M; Bamedi T
    Int J Hematol; 2014 Nov; 100(5):443-9. PubMed ID: 25230816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First cases of severe congenital factor XIII deficiency in Southwestern Afghanistan in the vicinity of southeast of Iran.
    Hosseini S; Dorgalaleh A; Bamedi T; Tavakol K; Tabibian S; Naderi M; Alizadeh S; Varmaghani B; Shamsizadeh M; Rahimizadeh A; Ebrahimi S
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):908-11. PubMed ID: 26226252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran.
    Naderi M; Reykande SE; Dorgalaleh A; Alizadeh S; Tabibian S; Einollahi N; Moghaddam EM
    Blood Coagul Fibrinolysis; 2016 Jan; 27(1):97-100. PubMed ID: 26703985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Insights into Heterozygous Factor XIII Deficiency.
    Dorgalaleh A
    Semin Thromb Hemost; 2024 Mar; 50(2):200-212. PubMed ID: 36940714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
    Souri M; Biswas A; Misawa M; Omura H; Ichinose A
    Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation factor XIII and factor XIII deficiency.
    Dorgalaleh A; Rashidpanah J
    Blood Rev; 2016 Nov; 30(6):461-475. PubMed ID: 27344554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases.
    Naderi M; Alizadeh S; Kazemi A; Tabibian S; Zaker F; Bamedi T; Kashani Khatib Z; Dorgalaleh A
    Hematology; 2015 Mar; 20(2):112-8. PubMed ID: 25001244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII deficiency: an update.
    Schroeder V; Kohler HP
    Semin Thromb Hemost; 2013 Sep; 39(6):632-41. PubMed ID: 23929307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
    Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA
    Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental uniparental disomy as a rare cause of congenital severe factor XIII deficiency in a girl with only one heterozygous carrier parent.
    Shen MC; Chen M; Chang SP; Lin PT; Hsieh HN; Lin KH
    Pediatr Hematol Oncol; 2018; 35(7-8):442-446. PubMed ID: 30702381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
    Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran.
    Eshghi P; Cohan N; Lak M; Naderi M; Peyvandi F; Menegatti M; Karimi M
    Clin Appl Thromb Hemost; 2012; 18(1):100-3. PubMed ID: 22156982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis of Congenital Factor XIII Deficiency in Iran.
    Dorgalaleh A; Assadollahi V; Tabibian S; Shamsizadeh M
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):210-216. PubMed ID: 27879471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of Factor XIII and clinical manifestations of Factor XIII deficiency.
    Levy JH; Greenberg C
    Transfusion; 2013 May; 53(5):1120-31. PubMed ID: 22928875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premarital Screening Program for Congenital Factor XIII Deficiency in Iran.
    Daneshi M; Dorgalaleh A; Tabibian S; Safa M; Naderi M; Kazemi A
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII deficiency in Iran: a comprehensive review of the literature.
    Dorgalaleh A; Naderi M; Hosseini MS; Alizadeh S; Hosseini S; Tabibian S; Eshghi P
    Semin Thromb Hemost; 2015 Apr; 41(3):323-9. PubMed ID: 25615432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor XIII deficiency - not only a congenital bleeding disorder].
    Schött U; Astermark J; Zdanowski A; Strandberg K
    Lakartidningen; 2023 Apr; 120():. PubMed ID: 37099358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of factor XIII deficiency, data from comprehensive coagulation laboratory in Iran.
    Gheidishahran M; Dorgalaleh A; Tabibian S; Shams M; Sanei Moghaddam E; Khosravi S; Naderi M; Kahraze S; Lotfi F; Kazeme A; Safa M
    Blood Coagul Fibrinolysis; 2018 Jan; 29(1):87-91. PubMed ID: 29095761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
    Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL
    J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.